New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication

Documenti analoghi

• Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy
  di: Qin Wang, et al.
  Pubblicazione: (2024)
• Natural killer cells in cancer immunotherapy
  di: DanRu Wang, et al.
  Pubblicazione: (2024)
• The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
  di: Yalun Li, et al.
  Pubblicazione: (2024)
• Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
  di: Zhijun Yuan, et al.
  Pubblicazione: (2024)
• Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
  di: Shiqi Li, et al.
  Pubblicazione: (2024)